Bremelanotide
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for Bremelanotide, covering 2011-02-23 to 2024-11-13. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 3, Bridging, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate the Efficacy and Safety of Subcutaneously Administered Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder (With or Without Decreased Arousal) [Phase 3]